Active ingredientPemirolastCat. No. P-P037-001CAS 69372-19-6Family · Pharmaceutical analytical standards
Pemirolast
An anti-allergic drug that stabilises mast cells and curbs the release of histamine and other allergy mediators; in Japan it was introduced as tablets, syrup and eye drops, while in the United States it was approved in 1999 as eye drops for allergic conjunctivitis. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?In Japan it was one of the medicines switched from prescription to over-the-counter status, both as anti-allergy eye drops and as an oral remedy for the nose.
Go to the active ingredient →Active ingredientPemirolastCat. No. P-P037-001CAS 69372-19-6
Active ingredientPemirolast Potassium SaltCat. No. P-P037-002CAS 100299-08-9
Isotopically labelled3-(Methyl-d3)pyridin-4,5,6-d3-2-amineCat. No. P-P037-003CAS 2247346-23-0
Isotopically labelledPemirolast-d6 Potassium SaltCat. No. P-P037-004
ImpurityPemirolast Impurity 1Cat. No. P-P037-005CAS 122149-47-7
ImpurityPemirolast Impurity 2Cat. No. P-P037-006CAS 113950-80-4![9-Methylpyrido[1,2-a]pyrimidin-2-one](https://img.vitasanlabs.com/vsl-struct/P-P037-007.svg?v=41e934f030)
Impurity9-Methylpyrido[1,2-a]pyrimidin-2-oneCat. No. P-P037-007CAS 16075-71-1
ImpurityPemirolast Impurity 3Cat. No. P-P037-008
ImpurityPemirolast Impurity 4Cat. No. P-P037-009
ImpurityPemirolast Impurity 5Cat. No. P-P037-010No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.